ZYMAXID (Allergan, Inc.)
Welcome to the PulseAid listing for the ZYMAXID drug offered from Allergan, Inc.. This Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | gatifloxacin |
SUBSTANCE NAME: | GATIFLOXACIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-05-19 |
END MARKETING DATE: | 0000-00-00 |
ZYMAXID HUMAN PRESCRIPTION DRUG Details:
Item Description | ZYMAXID from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2010-05-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0023-3615_2ced5ec1-e50f-45ae-acdf-db50920f2d38 |
PRODUCT NDC: | 0023-3615 |
APPLICATION NUMBER: | NDA022548 |
Other GATIFLOXACIN Pharmaceutical Manufacturers / Labelers: